IL6 and depressive symptom measurement: The final model for hot/coldness in hands/feet included worse fatigue/anxiety/depression (26%), higher pro-inflammatory IFN-γ (18%), worse baseline neuropathy (14%), taxane chemotherapy (11%), lower IL-6 (9%), lower anti-inflammatory IL-10 (9%), and lower BMI (6.5%).